In addition to the tumour size and the axillary lymph node involvement, other well-established prognostic factors currently used in breast cancer include histological subtype or grade, estrogen (ER) and progesterone (PR) receptor status, HER2 amplification, and Ki67 proliferation index [4,5]. This evidence concerns the gene PGR and neoplasm.